KJERISTA TIPTON: Open Payments
NPI 1114502754 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,451 in 69 payments from 20 companies in 2025. Trend: 2023 $1,375 · 2024 $1,671 · 2025 $1,451
Food & beverage: $1,451
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $332 |
| ABBVIE INC. | 9 | $188 |
| Janssen Biotech, Inc. | 3 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $109 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| PFIZER INC. | 4 | $86 |
| Daiichi Sankyo Inc. | 4 | $62 |
| Dendreon Pharmaceuticals LLC | 2 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $50 |
Products named: RYBREVANT, EPKINLY, Nubeqa, Enhertu, SCEMBLIX, KISQALI, Fabhalta, VENCLEXTA.
Industry payments across OK — which companies pay providers there.
